The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)2 NCS2, on the haematopoietic response of Ehrlich tumour-bearing mice

European Journal of Pharmacology

Volumn 439, Issue 1-3, 2002, Pages 35-42

  Valadares, Marize C ^a   Queiroz, Mary L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bis cyclopentadienylditiocianatetitanium (IV); Ehrlich ascites tumour; Metallocene; Myelopoiesis; Titanocene Dichloride

Indexed keywords

ANTINEOPLASTIC AGENT; DICYCLOPENTADIENYLDITIOCIANATETITANIUM; HALOGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TITANIUM DERIVATIVE; TITANOCENE DICHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CANCER MODEL; CANCER SURVIVAL; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; EHRLICH ASCITES TUMOR; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CARCINOMA, EHRLICH TUMOR; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; SPLEEN; SURVIVAL ANALYSIS;

EID: 0037192603     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01411-5     Document Type: Article

References (32)

1. Fluorine-18 Fluorodeoxyglucose slenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation
2. Pharmacological applications of inorganic complexes
3. Bis-cyclopentadyenyl compounds of Ti, Zr, V, Nb and Ta
4. Enhanced anti-cancer activities of some derivatives of titanocene dichloride
5. Cisplatin and analogues: Discovery, mechanism of action and clinical pharmacology
6. Anti-proliferative activity and mechanism of action of titanocene dichloride
7. Human granulocyte-macrophage colony stimulating factor is a growth factor on a variety of cell types of non-hematopopietic origin
8. Antitumor metallocene: Structure activity studies and interactions with biomolecules
9. Myelopoietic response in tumor-bearing mice by an aggregated polymer from Aspergillus oryzae
10. Effects of a green algae Chlorella vulgaris on the response of the host hematopoietic system to intraperitoneal Ehrlich ascites tumor transplantation in mice
11. Titanocene Dichoride: The first metallocene with cancerostatic activity
12. Tumor inhibition by titanocene dichloride: First clues to the mechanism of action
13. Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with Titanocene Dichloride
14. Tumour inhibition by titanocene complexes: Influence on xenografted human adenocarcinomas of the gastrointestinal tract
15. Antitumor activity of titanocene in xenografted human renal-cell carcinoma
16. Antitumour Metallocenes: New developments and toxicologic features
17. 2 (X=F, Cl, Br, I and NCS) and their application in buffered solution as a method for suppressing drug-induced side effects
18. Tumor inhibition by metallocenes: Activity against leukemias and detection of the systemic effect
19. Tumor inhibition by titanocene complexes: Activity against Sarcoma 180
20. Inhibition of human topoisomerase II by the antitumour metallocenes
21. Phase I clinical trial of a day-1,-3,-5 every week schedule with titanocene dichloride (MKT5) in patients with advanced cancer - A study of phase I study group of the American for Medical Oncology (AIO) of German Cancer Society
22. Factors of inluence in the activity of titanocenes in the homogenous catalyses of polymerizationof polystyrene
23. Adjuvant effect of Pluchea quitoc extract on the resistance of tumor bearing mice by modulation of the host hematopoietic response
24. Platinun compounds: A new class of potent antitumour agents
25. Ehrlich tumor stimulates extramedular hematopoiesis in mice without secreting identifiable colony-stimulating factors and without engagement of host T cells
26. Early tumour effect on splenic Th lymphocytes in mice
27. Ehrlich ascites tumour unbalances splenic populations and reduces responsiveness of T cells to Staphylococus aureus enterotoxin B stimulation
28. Tumor inhibition and hematopoietic stimulation in mice by a synthetic copper-ATP complexes
29. Development of splenic natural suppressor (NS) cells in Ehrlich tumour-bearing mice
30. Growth and differentiation of bone marrow haematopoietic cells in mice bearing Ehrlich ascite tumour and treated with dycyclopentadienyildichlorotitanium (IV)
31. Human tumour xenografts in nude mice: Chemotherapy trials with Titanocene Dichloride in different dosages